Matrixx Initiatives, Inc. (NASDAQ:MTXX)

Deandra88 (72.24) Submitted: 4/29/2008 4:27:32 PM : Start Price: $13.64 MTXX Score: -34.07

With the double failure to produce enough flu vaccine and produce the right strain of vaccine in the last two years it is inevitable that consumer confidence will focus on drugs with a concentration on the over-the-counter homeopathic, variety.

Their products are flying off the shelf in Duane Reade in NY, and I'm doing hands on research of their product placements in this popular drug store chain and other chains, and I'm happy to see their placement is prime eye-level shelving, with orientation toward the front of the store.

On a personal level, I am greatly impressed with the results of preventing a minor cold from changing into a major one.

My overall rational is that with their commercials and homeopathy being on the rise due to many conventional healthcare failures, an affordable share price and positive consumer reviews, this is a company that could prove attractive to a buy-out by a larger pharmaceutical company looking to grab some market share. I consider this a good value stock, and I've bought shares at $13.46.